Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 10Tumor-Agnostic 3Gynecologic 3Gastrointestinal 3Genitourinary 2Sarcoma 1Other hematologic neoplasm 1Other 1Head & Neck 1Dermatologic 1

Conditions

Ovarian Neoplasms 2Uterine Cervical Neoplasms 1Testicular Germ Cell Tumor 1Sarcoma 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1

Interventions

Paclitaxel 268Carboplatin 264Cisplatin 194Bevacizumab 135pembrolizumab 99Surveys and Questionnaires 84Radiotherapy 77Cyclophosphamide 75olaparib 67Blood Specimen Collection 65Drug Therapy 62Hyperthermic Intraperitoneal Chemotherapy 60Gemcitabine 60niraparib 56Topotecan 56Brachytherapy 54liposomal doxorubicin 52Taxes 47Docetaxel 46Magnetic Resonance Spectroscopy 43Letrozole 36Cytoreduction Surgical Procedures 36Filgrastim 33Biopsy 33Surgical Procedures, Operative 32durvalumab 31Specimen Handling 31Doxorubicin 31Nivolumab 30Albumin-Bound Paclitaxel 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Hypnosis × Gynecologic × Clear all
NCT07614620 2026-05-29

HYPNO-AJA2

Institut Bergonié

Phase NA Not yet recruiting
70 enrolled
BreastGenitourinaryGynecologicSarcoma

Testicular Germ Cell Tumor, Breast Neoplasms, Ovarian Neoplasms, Sarcoma

NCT04266886 2026-03-13

Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
152 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00293293 2017-12-28

Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine

Masonic Cancer Center, University of Minnesota

Phase NA Completed
43 enrolled 22 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡